No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over

Jane Warwick, Emanuela Falaschetti, Kenneth Rockwood, Arnold Mitnitski, Lutgarde Thijs, Nigel Beckett, Christopher Bulpitt, Ruth Peters

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish
    JournalBMC Medicine
    Issue number1
    Publication statusPublished - 2015

    Cite this